Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study.
Petersenn S, Farrall AJ, De Block C, Melmed S, Schopohl J, Caron P, Cuneo R, Kleinberg D, Colao A, Ruffin M, Hermosillo Reséndiz K, Hughes G, Hu K, Barkan A.
Petersenn S, et al. Among authors: cuneo r.
Pituitary. 2014 Apr;17(2):132-40. doi: 10.1007/s11102-013-0478-0.
Pituitary. 2014.
PMID: 23529827
Free PMC article.
Clinical Trial.